These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15261948)

  • 1. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium.
    Agbulut O; Vandervelde S; Al Attar N; Larghero J; Ghostine S; Léobon B; Robidel E; Borsani P; Le Lorc'h M; Bissery A; Chomienne C; Bruneval P; Marolleau JP; Vilquin JT; Hagège A; Samuel JL; Menasché P
    J Am Coll Cardiol; 2004 Jul; 44(2):458-63. PubMed ID: 15261948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure.
    Bonaros N; Rauf R; Werner E; Schlechta B; Rohde E; Kocher A; Bonatti J; Laufer G
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):249-55. PubMed ID: 17925321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wanted! The best cell for cardiac regeneration.
    Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2004 Jul; 44(2):464-6. PubMed ID: 15261949
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats.
    Ott HC; Bonaros N; Marksteiner R; Wolf D; Margreiter E; Schachner T; Laufer G; Hering S
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):627-34. PubMed ID: 15037282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design.
    Mansour S; Roy DC; Bouchard V; Nguyen BK; Stevens LM; Gobeil F; Rivard A; Leclerc G; Reeves F; Noiseux N
    J Cardiovasc Transl Res; 2010 Apr; 3(2):153-9. PubMed ID: 20560029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy.
    Memon IA; Sawa Y; Miyagawa S; Taketani S; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):646-53. PubMed ID: 16153908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium.
    Leor J; Guetta E; Feinberg MS; Galski H; Bar I; Holbova R; Miller L; Zarin P; Castel D; Barbash IM; Nagler A
    Stem Cells; 2006 Mar; 24(3):772-80. PubMed ID: 16195418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.
    Yerebakan C; Kaminski A; Westphal B; Donndorf P; Glass A; Liebold A; Stamm C; Steinhoff G
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1530-9.e3. PubMed ID: 21664627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cells in cardiac repair.
    Henning RJ
    Future Cardiol; 2011 Jan; 7(1):99-117. PubMed ID: 21174514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair.
    Rufaihah AJ; Haider HK; Heng BC; Ye L; Tan RS; Toh WS; Tian XF; Sim EK; Cao T
    Regen Med; 2010 Mar; 5(2):231-44. PubMed ID: 20210583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.
    Bartunek J; Vanderheyden M; Vandekerckhove B; Mansour S; De Bruyne B; De Bondt P; Van Haute I; Lootens N; Heyndrickx G; Wijns W
    Circulation; 2005 Aug; 112(9 Suppl):I178-83. PubMed ID: 16159812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
    Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
    Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year follow-up of the local autologous transplantation of CD133+ enriched bone marrow cells in patients with myocardial infarction.
    Ahmadi H; Farahani MM; Kouhkan A; Moazzami K; Fazeli R; Sadeghian H; Namiri M; Madani-Civi M; Baharvand H; Aghdami N
    Arch Iran Med; 2012 Jan; 15(1):32-5. PubMed ID: 22208441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor.
    Gmeiner M; Zimpfer D; Holfeld J; Seebacher G; Abraham D; Grimm M; Aharinejad S
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1238-45. PubMed ID: 21329947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of electrostimulation with cell transplantation in ischemic heart disease.
    Shafy A; Lavergne T; Latremouille C; Cortes-Morichetti M; Carpentier A; Chachques JC
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):994-1001. PubMed ID: 19660354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency.
    Flores-Ramírez R; Uribe-Longoria A; Rangel-Fuentes MM; Gutiérrez-Fajardo P; Salazar-Riojas R; Cervantes-García D; Treviño-Ortiz JH; Benavides-Chereti GJ; Espinosa-Oliveros LP; Limón-Rodríguez RH; Monreal-Puente R; González-Treviño JL; Rojas-Martínez A
    Cardiovasc Revasc Med; 2010; 11(2):72-8. PubMed ID: 20347795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure.
    Bonaros N; Rauf R; Wolf D; Margreiter E; Tzankov A; Schlechta B; Kocher A; Ott H; Schachner T; Hering S; Bonatti J; Laufer G
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1321-8. PubMed ID: 17140950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats.
    Rong SL; Lu YX; Liao YH; Wang XL; Wang YJ; Chang C; Wang YQ; Liu QY; Gao YZ; Mi SH
    Chin Med J (Engl); 2008 Feb; 121(4):347-54. PubMed ID: 18304469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells.
    Shi M; Ishikawa M; Kamei N; Nakasa T; Adachi N; Deie M; Asahara T; Ochi M
    Stem Cells; 2009 Apr; 27(4):949-60. PubMed ID: 19353523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells.
    Ma N; Ladilov Y; Moebius JM; Ong L; Piechaczek C; Dávid A; Kaminski A; Choi YH; Li W; Egger D; Stamm C; Steinhoff G
    Cardiovasc Res; 2006 Jul; 71(1):158-69. PubMed ID: 16730684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.